ÂÜÀòÂÒÂ×

Dr. Ralf Clemens is a development advisor and SAB member and a leading expert in vaccinology with more than 30 years of experience in global vaccine development. He has developed and brought to licensure more than 25 different vaccines globally. Dr. Clemens served as a Senior Vice President of Development for the Global Vaccine Business Unit at Takeda Pharmaceuticals International, and prior to that as Global Head of Vaccine Development for Novartis Vaccines as well as Vice President, Global Clinical R&D of GlaxoSmithKline Vaccines and of GSK’s Pharmaceuticals and Vaccines division in Latin America. Dr. Clemens is founder and president of GRID EUROPE (Global Research in Infectious Diseases EUROPE), and serves as an advisor to the Bill & Melinda Gates Foundation. He is a member of the board of trustees of the Africa Research Excellence Fund (AREF) and of the International Vaccine Institute IVI in Korea as well as a member of the supervisory board at CureVac AG. He also serves on the scientific committees of GHIT, CEPI, and Valneva SE. Dr. Clemens is the author of more than 170 publications and 250 presentations in the fields of vaccines, immunization, and tropical medicine. He holds a M.D. from the University of Mainz, Germany and an executive business degree from the Wharton Business School, Philadelphia